PWM
NUVB icon

Palumbo Wealth Management’s Nuvation Bio NUVB Stock Holding History

Palumbo Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$433K Sell
100,963
-62,793
-38% -$350K 0.11% 139
2025
Q4 		$1.47M Buy
163,756
+29,895
+22% +$185K 0.36% 54
2025
Q3 		$495K Buy
133,861
+20,195
+18% +$55K 0.16% 91
2025
Q2 		$222K Buy
113,666
+4,023
+4% +$8.38K 0.07% 175
2025
Q1 		$193K Buy
109,643
+44,283
+68% +$101K 0.06% 165
2024
Q4 		$174K Buy
65,360
+48,914
+297% +$126K 0.06% 158
2024
Q3 		$37.7K Sell
16,446
-11,904
-42% -$36.3K 0.01% 156
2024
Q2 		$82.8K Buy
28,350
+8,281
+41% +$25.3K 0.04% 141
2024
Q1 		$73.1K Buy
+20,069
New +$38.5K 0.03% 133

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Palumbo Wealth Management's NUVB Position: Q1 2026 in Review

Palumbo Wealth Management reduced its Nuvation Bio (NUVB) stake by 38% in Q1 2026, selling an estimated $350K and leaving 100,963 shares worth $433K. The position accounts for 0.11% of the portfolio, ranked #139.

Palumbo Wealth Management first reported a position in NUVB in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.47M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Palumbo Wealth Management held 100,963 shares of Nuvation Bio worth $433K as of Q1 2026.
  • Palumbo Wealth Management sold 62,793 Nuvation Bio shares in Q1 2026, an estimated $350K.
  • Nuvation Bio made up 0.11% of Palumbo Wealth Management's portfolio in Q1 2026, its #139 holding.
  • Palumbo Wealth Management first reported a position in Nuvation Bio in Q1 2024 and has held it in 9 quarters since.
  • Palumbo Wealth Management's Nuvation Bio position peaked at $1.47M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.